Trial · NCT05674487
Registered outcomes33
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 33
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | cesarean section | Day 1 | Incidence of cesarean section defined as a cesarean birth regardless of the indication |
| Secondary | duration of labor | Day 1 | Mean duration of labor (duration between admission to the labor room and delivery) |
| Secondary | duration between cervical ripening and delivery | Day 1 | Mean duration between cervical ripening and delivery |
| Secondary | oxytocin use | Day 1 | Incidence of oxytocin use (median of the maximal administered dosage) |
| Secondary | operative delivery | Day 1 | Incidence of operative delivery (vacuum, forceps, spatula) |
| Secondary | postpartum hemorrhage | Day 3 | Incidence of postpartum hemorrhage defined by blood loss \>500mL (defined according to the CNGOF criteria) |
| Secondary | Mean total blood loss | Day 3 | Mean total blood loss (mL) |
| Secondary | intra-uterine infectious | Day 5 | Incidence of intra-uterine infectious defined by a fever (maternal temperature equal to or greater than 38°C twice), associated to at least one of the two criterion: persistent fetal tachycardia \> 160 bpm, or purulent amniotic fluid (defined according to the CNGOF criteria). |
| Secondary | iron administration | Day 5 | Incidence of postpartum intravenous iron administration |
| Secondary | transfusion | Day 5 | Incidence of transfusion of blood products or blood |
| Secondary | maternal thromboembolism event | Day 5 | Incidence of maternal thromboembolism event (deep venous thrombosis diagnosed using leg Doppler ultrasound or pulmonary embolism diagnosed using computed tomographic pulmonary angiography) |
| Secondary | maternal satisfaction | Day 5 | Incidence of maternal satisfaction with a satisfaction questionnaire derived from the childbirth experience questionnaire and satisfaction questionnaire of TRAAP2 study |
| Secondary | Mean duration of hospitalization | Day 5 | Mean duration of hospitalization |
| Secondary | umbilical artery lactic acid | Day 1 | Incidence of umbilical artery lactic acid greater than 10mmol/l |
| Secondary | umbilical artery pH | Day 1 | Incidence of umbilical artery pH of less than 7,05 |
| Secondary | neonatal Apgar Score | Day 1 | Incidence of neonatal 5 minutes Apgar Score of less than 7 |
| Secondary | neonatal hypoglycemia | Day 5 | Incidence of neonatal hypoglycemia (blood glucose \< 35 mg/L) requiring intravenous therapy |
| Secondary | neonatal intensive care | Day 5 | Incidence of admission to neonatal intensive care unit or intermediate care unit |
| Secondary | neonatal length of hospital stay | Day 5 up to Month 2 | Mean neonatal length of hospital stay |
| Secondary | neonatal death before discharge | Day 1 up to Month 2 | Incidence of neonatal death before discharge |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05674487/registered